Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 6:51 pm Sale | 13G | aTYR PHARMA INC ATYR | Logos Global Management LP | 1,750,000 2.100% | -4,050,000 (-69.83%) | View |
| 2024-10-15 5:01 pm Purchase | 13G | aTYR PHARMA INC ATYR | Point72 Asset Management L.P. | 5,039,846 6.200% | 5,039,846 (New Position) | View |
| 2024-10-07 1:36 pm Purchase | 13G | aTYR PHARMA INC ATYR | FEDERATED HERMES INC. FHI | 14,666,600 19.350% | 4,497,000 (+44.22%) | View |
| 2024-02-14 1:43 pm Sale | 13G | aTYR PHARMA INC ATYR | LYTTON LAURENCE W | 585,013 1.000% | -3,855,175 (-86.82%) | View |
| 2024-02-13 4:30 pm Sale | 13G | aTYR PHARMA INC ATYR | Stonepine Capital Management LLC | 482,258 0.800% | -4,260,904 (-89.83%) | View |
| 2024-02-09 08:35 am Purchase | 13G | aTYR PHARMA INC ATYR | FMR LLC | 8,784,009 14.999% | 4,432,602 (+101.87%) | View |
| 2024-01-18 10:17 am Purchase | 13G | aTYR PHARMA INC ATYR | FEDERATED HERMES INC. FHI | 10,169,600 17.370% | 4,938,000 (+94.39%) | View |
| 2024-01-02 12:21 pm Purchase | 13G | aTYR PHARMA INC ATYR | Logos Global Management LP | 5,800,000 9.900% | 5,800,000 (New Position) | View |
| 2023-02-22 1:40 pm Purchase | 13G | aTYR PHARMA INC ATYR | LYTTON LAURENCE W | 4,440,188 8.700% | 4,440,188 (New Position) | View |
| 2023-02-17 5:04 pm Purchase | 13G | aTYR PHARMA INC ATYR | Stonepine Capital Management LLC | 4,569,433 8.900% | 4,569,433 (New Position) | View |
| 2023-02-14 4:07 pm Sale | 13G | aTYR PHARMA INC ATYR | Venrock Healthcare Capital Partners II L.P. | 1,171,436 4.000% | -393,564 (-25.15%) | View |
| 2023-02-09 08:23 am Purchase | 13G | aTYR PHARMA INC ATYR | FMR LLC | 4,351,407 14.999% | 182,806 (+4.39%) | View |
| 2023-02-01 10:29 am Purchase | 13G | aTYR PHARMA INC ATYR | FEDERATED HERMES INC. FHI | 5,231,600 18.030% | 5,231,600 (New Position) | View |
| 2022-02-14 4:41 pm Sale | 13G | aTYR PHARMA INC ATYR | Ikarian Capital LLC | 35,048 0.100% | -853,532 (-96.06%) | View |
| 2022-02-14 4:17 pm Sale | 13G | aTYR PHARMA INC ATYR | Venrock Healthcare Capital Partners II L.P. | 1,565,000 5.600% | -250,000 (-13.77%) | View |
| 2022-02-14 4:00 pm Purchase | 13G | aTYR PHARMA INC ATYR | TANG CAPITAL PARTNERS LP | 1,113,453 4.000% | 50,000 (+4.70%) | View |
| 2022-02-14 3:22 pm Sale | 13G | aTYR PHARMA INC ATYR | Alyeska Investment Group L.P. | 0 0.000% | -842,554 (Position Closed) | View |
| 2022-02-14 1:26 pm Unchanged | 13G | aTYR PHARMA INC ATYR | FEDERATED HERMES INC. FHI | 5,222,250 18.790% | 0 (Unchanged) | View |
| 2022-02-09 09:09 am Purchase | 13G | aTYR PHARMA INC ATYR | FMR LLC | 4,168,601 14.999% | 2,492,721 (+148.74%) | View |
| 2021-10-08 2:22 pm Purchase | 13G | aTYR PHARMA INC ATYR | FEDERATED HERMES INC. FHI | 5,222,250 19.860% | 3,607,250 (+223.36%) | View |